RESPIRERX PHARMACEUTICALS INC.
Profile
Company Names
RESPIRERX PHARMACEUTICALS INC.
CORTEX PHARMACEUTICALS INC/DE/
Addresses
126 VALLEY ROAD, SUITE C, GLEN ROCK, NJ 07452
7700 IRVINE CENTER DRIVE, SUITE 750, IRVINE, CA 92618
15241 BARRANCA PKWY, IRVINE, CA 92618
Phone Numbers
(201) 444-4947
949 727 3157
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$14,460,462.00
Number of Funding Rounds:
14
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
14
2020-07-28
$0.00
$2,000,000.00
$2,000,000.00
Equity, Debt
13
2020-07-02
$193,250.00
$193,250.00
$0.00
Debt
12
2018-09-12
$250,750.00
$1,500,000.00
$1,249,250.00
Equity
11
2017-08-29
$75,000.00
$1,150,000.00
$1,075,000.00
Equity
10
2017-03-10
$50,000.00
$1,500,000.00
$1,450,000.00
Equity
9
2016-12-29
$185,000.00
$3,000,000.00
$2,815,000.00
Equity
8
2016-01-08
$100,000.00
$2,500,000.00
$2,400,000.00
Equity
7
2015-08-28
$721,180.00
$3,000,000.00
$2,278,820.00
Equity
6
2014-11-05
$238,500.00
$1,000,000.00
$761,500.00
Equity, Debt
5
2014-03-18
$753,220.00
$1,500,000.00
$746,780.00
Equity
4
2012-08-10
$3,832,214.00
$3,832,214.00
$0.00
Equity
3
2011-10-20
$675,057.00
$675,057.00
$0.00
Equity
2
2010-01-15
$1,500,000.00
$1,500,000.00
$0.00
Debt
1
2009-07-31
$5,886,291.00
$5,886,291.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHARLES
J.
CASAMENTO
DIRECTOR
JAMES
H.
COLEMAN
EXECUTIVE OFFICER
TIMOTHY
JONES
EXECUTIVE OFFICER, DIRECTOR
ARNOLD
S.
LIPPA
EXECUTIVE OFFICER, DIRECTOR
JAMES
S.
MANUSO
EXECUTIVE OFFICER, DIRECTOR
JAMES
S.J.
MANUSO
EXECUTIVE OFFICER, DIRECTOR
JEFF
E.
MARGOLIS
EXECUTIVE OFFICER, DIRECTOR
RICHARD
PURCELL
EXECUTIVE OFFICER
ROBERT
N.
WEINGARTEN
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2020-07-02
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity, Debt
2020-07-28
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-09-12
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-08-29
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-03-10
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-12-29
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-01-08
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-08-28
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity, Debt
2014-11-05
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2014-03-18
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2012-08-10
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2011-10-20
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2010-01-15
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2009-07-31
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
